Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacokinetics: Drug–Drug Interactions

Pharmacokinetics: Drug–Drug Interactions

Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...

Drug toxicity: Drug–Drug Interaction

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...

Factors Affecting Protein-Drug Binding: Drug Interactions

Factors Affecting Protein-Drug Binding: Drug Interactions

Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...

Combined Effects of Drugs: Antagonism

Combined Effects of Drugs: Antagonism

The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...

Drug-Receptor Interactions

Drug-Receptor Interactions

Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Improving Interoperability in ePrescribing.

Interactive journal of medical research·2013

Same author

Correction: Improving Interoperability in ePrescribing.

Interactive journal of medical research·2013

Same author

Acquisition cost of dispensed drugs in individuals with multiple medications--a register-based study in Sweden.

Health policy (Amsterdam, Netherlands)·2011

Same author

Increasing polypharmacy - an individual-based study of the Swedish population 2005-2008.

BMC clinical pharmacology·2010

Same author

Physicians' attitudes towards eprescribing: a comparative web survey in Austria and Sweden.

Informatics in primary care·2010

Same author

Assessment of regional variation in polypharmacy.

Pharmacoepidemiology and drug safety·2010

Search research articles

Related Experiment Video

Updated: Jun 23, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

Avoiding drug-drug interactions.

Bengt Astrand¹

¹School of Pure and Applied Natural Sciences, University of Kalmar and Apoteket AB, Kalmar, Sweden. bengt.astrand@hik.se

|May 15, 2009

Summary

Access to comprehensive drug data is crucial for preventing drug-drug interactions (DDIs) and adverse drug reactions (ADRs). Improved data accessibility at the point of care can enhance patient safety and healthcare outcomes.

Area of Science:

Pharmacology
Health Informatics
Patient Safety

Background:

Drug combinations can lead to dangerous drug-drug interactions (DDIs) and adverse drug reactions (ADRs), often necessitating hospital care.
Government initiatives collect prescribing data to inform healthcare providers about patient drug therapies.

Observation:

Prescribing data for dispensed drugs is accessible in Sweden and Denmark to prescribers, pharmacists, and patients.
Current utilization of this data in healthcare is limited, despite positive pilot project outcomes.
Enhanced accessibility of drug information is required for effective clinical application.

Findings:

Comprehensive and reliable information on all individual drug use is essential at the point of care to prevent DDIs.
Maintaining updated and accurate knowledge databases for clinically relevant DDIs is critical.

More Related Videos

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

High-throughput Identification of Synergistic Drug Combinations by the Overlap² Method

Published on: May 21, 2018

Related Experiment Videos

Last Updated: Jun 23, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

High-throughput Identification of Synergistic Drug Combinations by the Overlap² Method

Published on: May 21, 2018

Future pharmacotherapy may integrate genomic and proteomic data for personalized medicine.

Implications:

Improving access to complete medication records can significantly reduce the incidence of adverse drug events.
Standardizing and enhancing the accessibility of drug-interaction databases is vital for clinical decision support.
Personalized medicine approaches, incorporating individual biological data, hold promise for optimizing drug therapy.